Clinical trial
Transnasal Therapy for Acute Migraine Attack
NCT04129567 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Transnasal Therapy for Acute Migraine Attack
- Lead sponsor
- Johns Hopkins University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 15, 2018
- Completion date
- November 15, 2019
- Enrollment
- 51 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.